Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 204
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging 2020 Fabris, LucaGringeri, EnricoGuglielmi, AlfredoGuido, MariaGiunta, Michela DiGambato, MartinaLasagni, AlbertoRossi, MassimoD'amati, Giulia + DIGESTIVE AND LIVER DISEASE - -
Necroptosis in Cholangiocarcinoma 2020 Sarcognato, SamanthaFabris, LucaCadamuro, MassimilianoGuido, Maria + CELLS - -
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 2020 Fabris L.Gaudio E. + NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY - -
Liver Matrix in Benign and Malignant Biliary Tract Disease 2020 Fabris, LucaCadamuro, Massimiliano + SEMINARS IN LIVER DISEASE - -
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 2020 Cadamuro M.Fabris L. + PLOS ONE - -
Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system 2020 Fabris, Luca + HEPATOLOGY - -
The Tumor Microenvironment in Cholangiocarcinoma Progression 2020 Fabris, Luca + HEPATOLOGY - -
Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment 2020 Fabris L. + JOURNAL OF HEPATOLOGY - -
Molecular pathogenesis of intrahepatic cholangiocarcinoma: from inflammation and cholestasis to a microenvironment-driven tumor 2019 Fabris LCadamuro M + - - Intrahepatic Cholangiocarcinoma: Diagnosis and Management
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 2019 Fabris L.Cadamuro M.Mariotti V. + NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY - -
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect? 2019 Cadamuro, MassimilianoFabris, Luca + CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY - -
Clinical outcome indicators in chronic hepatitis B and C: A primer for value based medicine in hepatology 2019 Fabris, Luca + LIVER INTERNATIONAL - -
Cell interactions in biliary diseases: Clues from pathophysiology and repair mechanisms to foster early assessment 2019 Fabris L.MERTENS, JOACHIM CARL PHILIPP + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
The Tumor Microenvironment and Immune Milieu of Cholangiocarcinoma 2019 Fabris, LucaMERTENS, JOACHIM CARL PHILIPP + LIVER INTERNATIONAL - -
Modulation of the TPH1/MAO-A/5HT/5HTR2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis 2019 Fabris, Luca + HEPATOLOGY - -
Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis 2019 Fabris, Luca + BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE - -
Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis 2019 Fabris L. + FASEB JOURNAL - -
β-Catenin and interleukin-1β–dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis 2018 Mariotti, ValeriaCadamuro, MassimilianoFabris, Luca + HEPATOLOGY - -
Animal models for cystic fibrosis liver disease (CFLD) 2018 MARIOTTI, VALERIACadamuro, MassimilianoFabris, Luca + BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE - -
Animal models of cholestasis: An update on inflammatory cholangiopathies 2018 Mariotti, ValeriaCadamuro, MassimilianoFabris, Luca + BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE - -
Mostrati risultati da 41 a 60 di 204
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile